Stamatoullas A, Ghesquieres H, Feugier P, Andre M, et al. Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study. Leuk Lymphoma 2022 Aug 17:1-9. doi: 10.1080/10428194.2022.2107204.
PMID: 35975738